We are live on ! Find out more
BIOSW

BioPlus Acquisition Corp. Warrants
BIOSW

Delisted

BIOSW was delisted on the 6th of October, 2023.

Back to rankings

51 hedge funds and large institutions have $5.12M invested in BioPlus Acquisition Corp. Warrants in 2022 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 3

35% more capital invested

Capital invested by funds: $3.79M → $5.12M (+$1.34M)

25% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 4

21% more funds holding

Funds holding: 42 → 51 (+9)

Holders
51
Holders Change
+9
Holders Change %
+21.43%
% of All Funds
0.86%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
5
Reduced
4
Closed
3
Calls
$1.94M
Puts
–
Net Calls
+$1.94M
Net Calls Change
+$31K

Top Buyers

Rank Fund Capital Flow
1
CS
Clear Street
New York
+$111K
2
MP
Mangrove Partners
Connecticut
+$37.8K
3
RA
Ramius Advisors
New York
+$36.6K
4
EFI
EHP Funds Inc
Canada
+$23.6K
5
SCM
Shaolin Capital Management
Florida
+$23.2K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$83K
2
FLC
Fifth Lane Capital
Texas
-$12K
3
UOC
UBS O'Connor
Illinois
-$9.43K
4
WAM
Wolverine Asset Management
Illinois
-$211
5
FTCM
Fir Tree Capital Management
New York
-$149

BIOSW Hedge Fund Activity: Q2 2022 in Review

51 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in BioPlus Acquisition Corp. Warrants (BIOSW) for Q2 2022, worth a combined $5.12M — up 35% from $3.79M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new BIOSW positions and 3 closed out — a net gain of 9 holders — while 5 added to existing stakes and 4 trimmed.

The largest buyer was Clear Street, adding an estimated $111K. The largest seller was Citadel Advisors, exiting entirely with an estimated $83K sold.

  • 51 institutional investors held BioPlus Acquisition Corp. Warrants (BIOSW) as of Q2 2022, up from 42 in Q1 2022.
  • Funds reported $5.12M of BioPlus Acquisition Corp. Warrants stock for Q2 2022, up 35% quarter-over-quarter.
  • 12 funds opened new BioPlus Acquisition Corp. Warrants positions in Q2 2022 and 3 closed out, a net change of +9 holders.
  • The largest BioPlus Acquisition Corp. Warrants buyer in Q2 2022 was Clear Street, an estimated $111K added.
  • The largest BioPlus Acquisition Corp. Warrants seller in Q2 2022 was Citadel Advisors, an estimated $83K sold.

Based on aggregated 13F filings for Q2 2022.